Pay in 4 interest-free payments of $6.99 Learn more
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12
According to the FDA's approval, the eligibility criteria are as follows: For Adults: A Body Mass Index (BMI) of 30 kg/m or greater (defined as obesity), OR a BMI of 27 kg/m or greater (defined as overweight) with at least one weight-related comorbidity, such as high blood pressure, type 2 diabetes, or high cholesterol
L-Carnitine and Acetyl L-Carnitine are two different forms of the same molecule, Carnitine, an amino acid naturally synthesised by the human body and plays an important role in cellular energy metabolism
For more on this peptide, see our complete Retatrutide research guide
Klinic providers will conduct a thorough assessment to confirm eligibility
faces an increase in demand for weight-loss treatments and diabetic medications, leading some healthcare providers to seek alternatives to the high-cost commercial drugs
Safety Considerations Common Side Effects Nausea, vomiting, diarrhea, decreased appetite, constipation, and abdominal pain Injection site reactions (redness, itching, swelling) Hypoglycemia (especially if used with insulin or sulfonylureas) Serious Risks Pancreatitis: Seek immediate medical attention for severe abdominal pain
